维普中文期刊产品整合服务
565篇 您的检索式:作者名="DAHLOF B"
    题名 作者 年代 出处 被引量
1Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hyoertensinon study (LIFE) ;A randomized trial against atenolol 显示文摘Dahlof B Devereux RB Kjeldsen SE 2002Lancet2002,359,:1
2The anglo-scandinavian cardiac outcomes trial lipid lowering arm: extended observations 2 years after trial closure显示文摘Sever PS Poulter NR Dahlof B 2008Eur Heart J2008,29,4:1
3Cardiovascular morbid-ity and mortality in the Losartan Intervention For Endpoint reductionin hypertension study(LIFE):a randomised trial against atenolol显示文摘Dahlof B Devereux RB Kjeldsen SE 2002Lancet2002,359,9311:1
4Efficacy and tolerability of losartan potassium and antenolol in patient with mild to moderate essential hypertension显示文摘Dahlof B Keller SE Makrisl L 1995Am J Hypertens1995,8,:1
5Racial differences in incident heart failure during antihypertensive therapy显示文摘Okin PM Kjeldsen SE Dahlof B 0,,:1
6Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hyoertensinon study (LIFE) :a randomized trial against atenolol 显示文摘Dahlof B Devereux RB Kjeldsen SE 2002Lancet2002,359,:1
7Effeets oflosartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy显示文摘Dahlof B Zanchetti A Diez J 2002J Hypertens2002,20,9:1
8lmproved antihypertensive efficiency of the felodipine-metoprolol extended-release tablet compared with each drug alone 显示文摘DAHLOF B JONSSON L BORGHOLST O 1993Blood Press1993,2,1:1
9Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) ransomised trial显示文摘Hansson L Zanchetti A Carruthers SG Dahlof B Elmfeldt D Julius S MenardJ Rahn KH Wedel H Westerling S 1998Lancet1998,351,21:1
10Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than average cholesterol concentrations, in the Anglo-Scandinavian Crdiac Outcome Trial-Lipid Lowering Arm (ASCOT-LLA): a muhicentre randomized controlled trial 显示文摘Sever PS Dahlof B Pouher NR 2003Lancet2003,361,:1
11Prevention of coronary and stroke events with atorvastatin in hepertensive patients who have aver- age or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT- LLA) :a multicentre randomized controlled trial 显示文摘Sever PS Dahlof B Poulter NR 2003Lancet2003,361,9364:1
12Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)显示文摘Poulter NR Wedel H Dahlof B 2005Lancet2005,366,:1
13Pre- stroke events with ator- vastatin in hypertensive patients who have aver-age or lower-than-average cholesterol comcentra- tions, in the anglo-scandinavian cardiac outcomes trial-ipid lowering arm (ASCOT-LLA): a multicen- tre randomised controlled trial显示文摘SEVER P S DAHLOF B vention of coronary and POULTER N R 2003Lancet2003,361,9364:1
14Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)显示文摘Poutter NR Wedel H Dahlof B 2005Lancet2005,366,9489:1
15Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial:a hypertensive population at high cardiovascular risk显示文摘Weber MA Bakris GL Dahlof B 2007Blood Press2007,16,1:1
16Female sex as an important determinant of lisinopril-induced cough显示文摘Os I Bratland B Dahlof B 1992Lancet1992,339,8789:1
17Cardiovascular mor- bidity and mortality in the losartan intervention for endpoint re- duction in hypertension study (LIFE) : a randomized trial against atenolo显示文摘Dahlof B Devereux RB Kjeldsen SE 2002Lancet2002,359,9311:1
18Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA):a multicenter randomised controlled trial显示文摘Sever PS Dahlof B Poulter NR 2003Lancet2003,361,:1
19Cariovascular morbidity and monalhym patients with diabetes in the losartan intervention for endpoint reduction in hypertension study ( UKPDS 23 ) 显示文摘Lindolm LH Ibsen H Dahlof B 1998BMJ1998,316,:1
20Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension(STOP-Hypertension) 显示文摘 Lindholm L Hansson LH 1991Lancet1991,338,8778:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费